Brief: Cosciens Provides Strategic Update
05/03/2026 22:22
March 5 (Reuters) - COSCIENS Biopharma Inc CSCI.TO: COSCIENS PROVIDES STRATEGIC UPDATE COSCIENS BIOPHARMA INC: MADE A STRATEGIC DECISION TO CEASE FUNDING ITS GERMAN SUBSIDIARIES, AETERNA ZENTARIS GMBH AND ZENTARIS IVF GMBH COSCIENS BIOPHARMA INC - GERMAN SUBSIDIARIES EXPECTED TO COMMENCE STRUCTURED INSOLVENCY PROCESS IN NEAR FUTURE COSCIENS BIOPHARMA INC - TO SURRENDER RIGHTS TO MACRILEN AND SIGNIFICANTLY REDUCE OPERATING EXPENSES Source text: ID:nGNX9VmSNm Further company coverage: CSCI.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update